New Zealand: A mining region on the rise for ASX-listed businesses
In recent times, New Zealand has honed in on ways the country can prosper.
Douugh (ASX:DOU): The best thing since sliced bread?
The story of the ASX fintech newcomer Douugh (ASX:DOU) is a tale of resilience.
MyFiziq (ASX:MYQ) is poised to disrupt the $45B medical imaging market
MyFiziq's (ASX:MYQ) advanced human imaging technology is a game-changer for the future of healthcare.
An extraordinary clash of conditions in investment markets
Investment markets have a host of both positive and negative factors fighting for supremacy.
Little Green Pharma (ASX:LGP) and the future of medicinal cannabis
Little Green Pharma's (ASX:LGP) recent partnership with HIF puts a spotlight on medicinal cannabis treatments.
What do investors stand to gain from Australia’s clinical trial landscape?
As healthcare giants scramble to create a COVID-19 vaccine, there is a growing interest in clinical trials and how exactly they work.
Renascor Resources (ASX:RNU): Poised to capture the gold rise
It's no secret that COVID-19 has caused investors to flock to gold stocks, seeing the precious…
Will Douugh (ASX:DOU) rise, or is it toast?
ASX newcomer Douugh (ASX:DOU) is one of the fastest-moving fintech stocks on the local share market,…
Cann Global (ASX:CGB): Disrupting the lucrative Australian cannabis market
The Australian cannabis and hemp industries have largely taken a back seat in 2020 as COVID-19…
Contenders for the kaolin crown – picking ASX winners in a $5B market few know much about
Contenders for the Kaolin Crown – picking ASX winners in a $5bn market few know much…